With the expertise and solid foundation of HKBU's clinical research centres, including Hong Kong Chinese Medicine Clinical Study Centre, Chinese Clinical Trial Registry (Hong Kong) and Chinese EQUATOR Centre, the CDS Group is building its data assets based on comprehensive data generated from Chinese Medicine clinical trials.

Driven by new drug discovery, the Integration of big data science and evidence-based medicine, CDS’s research focuses on the efficacy and safety of Chinese herbal medicines, including both single herbs and formulas, for the treatment of gastrointestinal diseases, such as colorectal cancer, irritable bowel syndrome (IBS), chronic constipation and inflammatory bowel disease (IBD).